Publication | Open Access

CSF Concentration of Crizotinib in Two ALK-Positive Non–Small-Cell Lung Cancer Patients with CNS Metastases Deriving Clinical Benefit from Treatment

OncologyMedicinePathologyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyLung CancerCsf Concentration